Claim · model-written summary
The NMS01 genome lacked human pathogenic genes.
- Taxon
- S. marcescens NMS01
Serratia marcescense0 - Outcome
- absence of human pathogenic genese0
Verbatim
e0“Genome analysis confirmed the absence of human pathogenic genes in S. marcescens NMS01, underscoring its safety and suitability as a biocontrol.”
Title
R. Sharanya; M. Gayathri; P. Renukadevi; et al. Journal of Agriculture and Food Research 2025. doi:10.1016/j.jafr.2025.102386
Other claims from this paper (15)
- Intervention effect Biohardening followed by NMS01 foliar application delayed tomato symptom onset.
- Intervention effect NMS01 treatment significantly reduced tomato disease incidence.
- Intervention effect NMS01 reduced viral titer in cowpea to DAC-ELISA OD values of 0.32–0.96 versus 3.26 in controls.
- Intervention effect NMS01 reduced tomato viral titer to DAC-ELISA OD values of 0.32–0.96 versus 3.26 in controls.
- Intervention effect NMS01 significantly reduced GBNV symptoms in cowpea.
- Intervention effect Treated tomato plants had a lower N gene copy number of 1.5 × 10 5 versus 2.4 × 10 6 in controls.
- Intervention effect NMS01 upregulated MAPKK1, WRKY33B, and PR1 in tomato.
- Observation AntiSMASH predicted genes for prodigiosin, thiopeptide, and hserlactone production.
- Observation NMS01 has 4,023 core genes.
- Observation NMS01 has 352 dispensable genes.
- Observation NMS01 has 664 unique genes, including MAMP genes.
- Intervention effect NMS01-treated field tomato plants reached 133.7 cm height versus 104.73 cm in controls.
- Intervention effect NMS01-treated field tomato plants had more flowers, 26.57 per plant versus 11.17 in controls.
- Intervention effect NMS01-treated field tomato plants had lower disease incidence of 12.3% versus 30.1% in controls.
- Recommendation The authors identify NMS01 as a promising biocontrol for GBNV management and tomato productivity.